XORTX Therapeutics Statistics

Total Valuation

XRTX has a market cap or net worth of $4.50 million. The enterprise value is $1.55 million.

Market Cap	4.50M
Enterprise Value	1.55M

Important Dates

The next estimated earnings date is Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

XRTX has 2.90 million shares outstanding. The number of shares has increased by 34.03% in one year.

Shares Outstanding	2.90M
Shares Change (YoY)	+34.03%
Shares Change (QoQ)	+19.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.66, with a Debt / Equity ratio of 0.03.

Current Ratio	7.66
Quick Ratio	7.08
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.36% and return on invested capital (ROIC) is -40.81%.

Return on Equity (ROE)	-29.36%
Return on Assets (ROA)	-33.14%
Return on Capital (ROIC)	-40.81%
Revenue Per Employee	n/a
Profits Per Employee	-$494,337
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.05% in the last 52 weeks. The beta is -0.19, so XRTX's price volatility has been lower than the market average.

Beta (5Y)	-0.19
52-Week Price Change	-56.05%
50-Day Moving Average	1.71
200-Day Moving Average	2.38
Relative Strength Index (RSI)	40.68
Average Volume (20 Days)	130,162

Short Selling Information

The latest short interest is 390, so 0.01% of the outstanding shares have been sold short.

Short Interest	390
Short Previous Month	31,275
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.34M
Pretax Income	-3.34M
Net Income	-1.48M
EBITDA	-3.30M
EBIT	-3.34M
Earnings Per Share (EPS)	-$0.64

Full Income Statement

Balance Sheet

The company has $3.08 million in cash and $83,706 in debt, giving a net cash position of $2.99 million or $1.03 per share.

Cash & Cash Equivalents	3.08M
Total Debt	83,706
Net Cash	2.99M
Net Cash Per Share	$1.03
Equity (Book Value)	2.70M
Book Value Per Share	0.93
Working Capital	2.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$4.41 million and capital expenditures -$1, giving a free cash flow of -$4.41 million.

Operating Cash Flow	-4.41M
Capital Expenditures	-1
Free Cash Flow	-4.41M
FCF Per Share	-$1.52

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.03%
Shareholder Yield	-34.03%
Earnings Yield	-32.94%
FCF Yield	-97.92%

Analyst Forecast

The average price target for XRTX is $14.00, which is 937.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	937.04%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 14, 2023. It was a reverse split with a ratio of 0.1111111:1.

Last Split Date	Nov 14, 2023
Split Type	Reverse
Split Ratio	0.1111111:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a